Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,168,620 | 943,771 | 456,649 | 239,758 | 315,520 |
| Marketable Securities | 521,713 | N/A | N/A | N/A | N/A |
| Receivables | 144 | 99 | 88 | 2,626 | 3,157 |
| TOTAL | $1,716,620 | $987,547 | $466,395 | $248,385 | $320,188 |
| Non-Current Assets | |||||
| PPE Net | 42,160 | 31,330 | 18,500 | 18,857 | 21,027 |
| Intangibles | 180 | 235 | 289 | 344 | 399 |
| Other Non-Current Assets | 69,006 | 47,640 | 3,832 | 3,760 | 3,348 |
| TOTAL | $111,346 | $79,205 | $22,621 | $22,961 | $24,774 |
| Total Assets | $1,827,966 | $1,066,752 | $489,016 | $271,346 | $344,962 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,094 | 5,944 | 5,069 | 1,639 | 4,569 |
| Accrued Expenses | 64,255 | 30,763 | 21,254 | 11,708 | 16,343 |
| Other current liabilities | 7,207 | 10,950 | 1,321 | 1,164 | 1,086 |
| TOTAL | $94,259 | $57,106 | $27,746 | $14,511 | $21,998 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,341 | 960 | 102 | N/A | N/A |
| Other Non-Current Liabilities | 69,473 | 58,445 | 11,295 | 12,075 | 12,497 |
| TOTAL | $69,473 | $70,221 | $69,075 | $69,003 | $90,118 |
| Total Liabilities | $163,732 | $127,327 | $96,821 | $83,514 | $112,116 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,429 | 60,846 | N/A | N/A | N/A |
| Common Shares | 2,277 | 1,847 | 1,584 | 1,240 | 1,216 |
| Retained earnings | -573,576 | -224,711 | -291,569 | -125,440 | -57,083 |
| Other shareholders' equity | -146 | -56 | -65 | 14 | -26 |
| TOTAL | $1,664,234 | $939,425 | $392,195 | $187,832 | $232,846 |
| Total Liabilities And Equity | $1,827,966 | $1,066,752 | $489,016 | $271,346 | $344,962 |